Blood Pressure and Clinical Outcomes in the International Stroke Trial

Background and Purpose— Among patients with acute stroke, high blood pressure is often associated with poor outcome, although the reason is unclear. We analyzed data from the International Stroke Trial (IST) to explore the relationship between systolic blood pressure (SBP), subsequent clinical events over the next 2 weeks, and functional outcome at 6 months in patients with acute stroke. Methods— We included in the analysis 17 398 patients from IST with confirmed ischemic stroke. A single measurement of SBP was made immediately before randomization. Clinical events within 14 days of randomization were recorded: recurrent ischemic stroke, symptomatic intracranial hemorrhage, death resulting from presumed cerebral edema, fatal coronary heart disease, and death. Survival and dependency were assessed at 6 months. Outcomes were adjusted for age, sex, clinical stroke syndrome, time to randomization, consciousness level, atrial fibrillation, and treatment allocation (aspirin, unfractionated heparin, both, or neither). Results— A U-shaped relationship was found between baseline SBP and both early death and late death or dependency: early death increased by 17.9% for every 10 mm Hg below 150 mm Hg (P <0.0001) and by 3.8% for every 10 mm Hg above 150 mm Hg (P =0.016). The rate of recurrent ischemic stroke within 14 days increased by 4.2% for every 10–mm Hg increase in SBP (P =0.023); this association was present in both fatal and nonfatal recurrence. Death resulting from presumed cerebral edema was independently associated with high SBP (P =0.004). No relationship between symptomatic intracranial hemorrhage and SBP was seen. Low SBP was associated with a severe clinical stroke (total anterior circulation syndrome) and an excess of deaths from coronary heart disease (P =0.002). Conclusions— Both high blood pressure and low blood pressure were independent prognostic factors for poor outcome, relationships that appear to be mediated in part by increased rates of early recurrence and death resulting from presumed cerebral edema in patients with high blood pressure and increased coronary heart disease events in those with low blood pressure. The occurrence of symptomatic intracranial hemorrhage within 14 days was independent of SBP.

[1]  M. Woodward,et al.  Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .

[2]  D. Johnston.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack , 2001, The Lancet.

[3]  P. Bath,et al.  The Effect of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Blood Pressure and Platelet Function in Acute Stroke , 2001, Cerebrovascular Diseases.

[4]  N. Wahlgren,et al.  Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. , 2000, Stroke.

[5]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[6]  S. Yusuf,et al.  Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53. , 2000 .

[7]  J. McNeil,et al.  The Risk of Intracerebral Haemorrhage with Smoking , 1999, Cerebrovascular Diseases.

[8]  J. Grotta,et al.  Hypertension and its treatment in the NINDS rt-PA Stroke Trial. , 1998, Stroke.

[9]  M. Buxton-Thomas,et al.  Pathophysiological Assessment of Nitric Oxide (Given as Sodium Nitroprusside) in Acute Ischaemic Stroke , 1998, Cerebrovascular Diseases.

[10]  Peter Sandercock,et al.  The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997, The Lancet.

[11]  K. Lees,et al.  Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke. , 1997, Stroke.

[12]  P. Bath,et al.  What Is the Correct Management of Blood Pressure in Acute Stroke? The Blood Pressure in Acute Stroke Collaboration , 1997 .

[13]  N. Taub,et al.  The Predictive Role of 24-Hour Compared to Casual Blood Pressure Levels on Outcome following Acute Stroke , 1997 .

[14]  C. Warlow,et al.  Are Simple Questions a Valid Measure of Outcome after Stroke , 1997 .

[15]  J. Slattery,et al.  Blood pressure and risk of stroke in patients with cerebrovascular disease , 1996, BMJ.

[16]  A. Kertesz,et al.  The Effects of Lifarizine in Acute Cerebral Infarction: A Pilot Safety Study , 1996 .

[17]  Pats-Collaborating-Group-.  Post-stroke antihypertensive treatment study. A preliminary result , 1995 .

[18]  Pats,et al.  Post-stroke antihypertensive treatment study. A preliminary result. , 1995, Chinese medical journal.

[19]  R. Kelley,et al.  Relation between blood pressure and outcome in intracerebral hemorrhage. , 1995, Stroke.

[20]  K. Asplund,et al.  The Prognostic Value of Admission Blood Pressure in Patients With Acute Stroke , 1993, Stroke.

[21]  J. Grotta,et al.  Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. , 1993, Archives of neurology.

[22]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[23]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.